Close

Articles

Maximising Drug Discovery Research

Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists should focus on the biological relevance of their candidate molecules as soon as possible in their research, to ensure a high probability of success...

State of the industry and the future of the sales force

eyeforpharma asked some of our key speakers for their insights on the “state of the industry and the future of the sales force”. Here’s what they had to say...How do you see the industry changing within the next five...

Bottlenecks in vaccine development: Eliminate from the beginning

Promising vaccine candidates, rising global demand and preparations for the next pandemic influenza have brought vaccine’s role into focus in the past years and resulted in an impressive Pharma market share and revenue (US$ 26billion) in 2009. This...

Bringing in the Green

A Green mind-set can lead to a black bottom line. Becoming environmentally friendly can help boost brand image and ROI—and pharma can get there with a few easy steps.First, with about 90,000 sales representatives on the road, the industry...

What do mapping and imaging techniques add to traditional spectroscopic analysis for pharmaceutical applications?

With bulk or traditional single point spectroscopy, one spectrum is collected for each sample using a single element detector with relatively short measurement times. For tablets, this provides one averaged measure of composition for either the whole tablet or...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read